2021
DOI: 10.1016/j.cllc.2020.10.010
|View full text |Cite
|
Sign up to set email alerts
|

STK11/LKB1 Mutation-positive Primary Thymic Mucinous Adenocarcinoma Accompanied by Cerebellar Metastasis: A Case Report and Literature Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
0
0
Order By: Relevance
“…In this study, we assess the feasibility of an innovative approach based on molecular testing. Reviewing genetic test results from previous studies on MAs, we found only two instances that indicated the presence of a KRAS mutation and STK11 deletion [ [6] , [8] , [9] ]. We conducted genetic testing on the patient's tissue samples twice, once from the mediastinal mass and once from the supraclavicular metastatic lymph nodes and both results were confirming the presence of the HER2 p.R678Q mutation.To our knowledge, this is the first reported case of HER-2 mutation in mediastinal MAs.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…In this study, we assess the feasibility of an innovative approach based on molecular testing. Reviewing genetic test results from previous studies on MAs, we found only two instances that indicated the presence of a KRAS mutation and STK11 deletion [ [6] , [8] , [9] ]. We conducted genetic testing on the patient's tissue samples twice, once from the mediastinal mass and once from the supraclavicular metastatic lymph nodes and both results were confirming the presence of the HER2 p.R678Q mutation.To our knowledge, this is the first reported case of HER-2 mutation in mediastinal MAs.…”
Section: Discussionmentioning
confidence: 92%
“…While it is crucial for diagnosis and treatment, determining the primary lesion remains a significant challenge. In this study, we have reviewed previous cases, including the results of immunohistochemistry, treatment modalities, and prognosis [ [5] , [6] , [7] , [8] , [9] , [10] , [12] ] ( Table 1 ). Immunohistochemical analysis of the cases reported previously exhibited similar characteristics to our case.…”
Section: Discussionmentioning
confidence: 99%